| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/17/2009 | EP1357115B1 Alkanoic acid derivatives, process for their production and use thereof |
| 06/17/2009 | EP1147205B1 High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site |
| 06/17/2009 | CN100500246C Use of dapsone as a neuroprotector in cerebral apoplexy |
| 06/17/2009 | CN100500211C Methods of therapy with thrombin derived peptides |
| 06/16/2009 | US7547802 Compounds for the treatment of metabolic disorders |
| 06/16/2009 | US7547779 Preparation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
| 06/16/2009 | US7547763 Sequences of an Ih ion channel and use thereof |
| 06/16/2009 | US7547715 Treating lung diseases selected from acute pneumonia, pulmonary fibrosis, pulmonary hypertension, chronic obstructive pulmonary disease (COPD), and asthma by administering (E)-[5-[2-[1-phenyl-1-(3-pyridyl)methylideneaminoxy]ethyl]-7,8-dihydronaphthalen-1-yloxy]acetic acid or a salt thereof |
| 06/16/2009 | US7547702 Glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents |
| 06/16/2009 | US7547697 Alkyl-pyridazine derivatives as 11b-HSD1 inhibitors |
| 06/16/2009 | US7547693 Piperidine derivative |
| 06/16/2009 | US7547674 By stimulating resident somatic stem cells; administering cytokines; kits |
| 06/16/2009 | US7547543 Retinoid-Related Orphan Receptor (ROR) receptor response element ; drug screening |
| 06/16/2009 | CA2451474C Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 06/16/2009 | CA2388314C Imidazole derivatives as phosphodiesterase vii inhibitors |
| 06/16/2009 | CA2385995C Quinuclidine compound and medicament comprising the compound as active ingredient |
| 06/16/2009 | CA2381097C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 06/16/2009 | CA2353063C Benzimidazole compounds that are vitronectin receptor antagonists |
| 06/11/2009 | WO2009073669A1 Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions |
| 06/11/2009 | WO2009073618A2 Compositions comprising hdac inhibitors and methods of their use in restoring stem cell function and preventing heart failure |
| 06/11/2009 | WO2009073616A2 Compositions comprising vascular and myocyte progenitor cells and methods of their use |
| 06/11/2009 | WO2009073186A1 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling |
| 06/11/2009 | WO2009072967A1 Triazolo [4,5-d] pyrimidine compounds for treatment of abdominal aortic aneurysms |
| 06/11/2009 | WO2009072915A1 New salts and crystal forms |
| 06/11/2009 | WO2009072649A1 4-arylphenyl derivative |
| 06/11/2009 | WO2009072635A1 Method for amplifying hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | WO2009072628A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 06/11/2009 | WO2009072626A1 Method for amplification of hematopoietic stem cell using heterocyclic compound |
| 06/11/2009 | WO2009072625A1 Amplification method for hematopoietic stem cells with heterocyclic compound |
| 06/11/2009 | WO2009072624A1 Method for amplification of hematopoietic stem cell using heterocyclic compound |
| 06/11/2009 | WO2009072581A1 Lactam compound or salt thereof, and ppar activator |
| 06/11/2009 | WO2009072527A1 Composition for autotransplantation or allotransplantation using dental pulp stem cell, and use of the composition |
| 06/11/2009 | WO2009072132A2 Beta glycolipids for the treatment of calcification related degenerative disorders |
| 06/11/2009 | WO2009071906A1 Derivatives of 1-[(imidazolidin-2-yl)imino)]indazole |
| 06/11/2009 | WO2009071905A2 Use of thiolatocobalamins as regulators/selective promoters of inducible and constitutive nitric oxide synthases |
| 06/11/2009 | WO2009071753A1 4-phenyl-1,3-thiazole and 4-phenyl-1,3-oxazole derivatives as cannabinoid receptor ligands |
| 06/11/2009 | WO2009071689A2 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 06/11/2009 | WO2009071687A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 06/11/2009 | WO2009071586A2 3-(2,2,2-trimethylhydrazinium) propionate salts for treating ischemic heart disease |
| 06/11/2009 | WO2009071585A1 Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate |
| 06/11/2009 | WO2009071405A1 Megestrol acetate for reducing the mortality and/or improving quality of life in cancer patients |
| 06/11/2009 | WO2009071213A1 Anti-glycation properties of asicatic acid and madecassic acid |
| 06/11/2009 | WO2009071097A1 Use of hypothermia inducing drugs |
| 06/11/2009 | WO2009071096A2 Combination of medical and physical cooling treatment of ischemic effects |
| 06/11/2009 | WO2009071095A2 Prevention of hyperthermia subsequent to hypothermia treatment of ischemia |
| 06/11/2009 | WO2009071094A2 Combination treatment of ischemic effects |
| 06/11/2009 | WO2009070974A1 Therapeutic composition containing amlodipine nicotinate and statins |
| 06/11/2009 | WO2009070973A1 Therapeutic composition containing amlodipine nicotinate and sartans |
| 06/11/2009 | WO2009053895A3 Quinoline urotensin-ii receptor antagonists |
| 06/11/2009 | WO2009033818A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033787A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033786A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033759A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033740A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033722A3 Use of a octreotide as a therapeutic agent |
| 06/11/2009 | WO2009033719A3 Use of a deslorelin and mastoparan as a therapeutic agent |
| 06/11/2009 | WO2009007112A4 Thrombomodulin for increasing reperfusion and preventing blood vessels obstruction |
| 06/11/2009 | WO2008019147A3 Use of exendins, exendin agonists and glp-1 receptor agonists for altering the concentration of fibrinogen |
| 06/11/2009 | WO2002003918A3 Treating neural conditions resulting from spinal cord contusions and other causes |
| 06/11/2009 | US20090149629 Corticotropin releasing factor peptide for use in the treatment of nervous system and hypertensive disorders; (cyclo 31-34)[Ac-Pro4,D-Phe12,Nle18,21,Glu31,Lys34]-sucker urotensin |
| 06/11/2009 | US20090149538 Aspirin-Triggered Lipid Mediators |
| 06/11/2009 | US20090149537 Use of Bile Acid or Bile Salt Fatty Acid Conjugates |
| 06/11/2009 | US20090149523 Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases |
| 06/11/2009 | US20090149513 Compositions of an Orally Active 1,2,4-Oxadiazole for Nonsense Mutation Suppression Therapy |
| 06/11/2009 | US20090149505 Metabotropic Glutamate Receptor-Potentiating Isoindolones |
| 06/11/2009 | US20090149481 Pharmaceutical composition and beverage composition comprising l-arginine |
| 06/11/2009 | US20090149476 3-[[6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-2,5-dimethyl-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine, used for the treatment of osteoporosis, restenosis, arteriosclerosis, nephropathy or retinopathy |
| 06/11/2009 | US20090149475 Thioxanthine Derivatives and Their Use as Inhibitors of MPO |
| 06/11/2009 | US20090149469 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as igf-ir inhibitors |
| 06/11/2009 | US20090149460 New Compounds |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149437 Thieno-pyridine derivatives as mek inhibitors |
| 06/11/2009 | US20090149431 Eplerenone Drug Substance Having High Phase Purity |
| 06/11/2009 | US20090149412 Method for Inhibition of Phospholamban Activity for the Treatment of Cardiac Disease and Heart Failure |
| 06/11/2009 | US20090149410 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/11/2009 | US20090149382 Modulation of lipid rafts |
| 06/11/2009 | US20090149381 Methods of regulating angiogenesis through stabilization of PEDF |
| 06/11/2009 | US20090149378 Glp-1 analogues |
| 06/11/2009 | US20090148543 Method for protecting humans against superficial vasodilator flush syndrome, |
| 06/11/2009 | US20090148491 Dual-Targeted Drug Carriers |
| 06/11/2009 | US20090148464 Preventive or therapeutic agent containing anti thioredoxin antibody polypeptide as an active ingredient for disorders |
| 06/11/2009 | US20090148421 Compositions comprising vascular and myocyte progenitor cells and methods of their use |
| 06/11/2009 | US20090148417 Carbon nanotubes serving as stem cell scaffold |
| 06/11/2009 | US20090148415 Treatment for Chronic Myocardial Infarct |
| 06/11/2009 | CA2743701A1 Compositions comprising hdac inhibitors and methods of their use in restoring stem cell function and preventing heart failure |
| 06/11/2009 | CA2743698A1 Compositions comprising vascular and myocyte progenitor cells and methods of their use |
| 06/11/2009 | CA2743682A1 Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells |
| 06/11/2009 | CA2708050A1 Method for expanding hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | CA2707689A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 06/11/2009 | CA2707671A1 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
| 06/11/2009 | CA2707669A1 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
| 06/11/2009 | CA2707667A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 06/11/2009 | CA2707663A1 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling |
| 06/11/2009 | CA2707488A1 Triazolo[4,5-d]pyrimidine compounds for treatment of abdominal aortic aneurysms |
| 06/10/2009 | EP2067863A2 Methods and compositions for diseases associated with amyloidosis |
| 06/10/2009 | EP2067862A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2067480A1 Musclin receptor and use thereof |
| 06/10/2009 | EP2067474A1 Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate |
| 06/10/2009 | EP2067473A2 Medical use of 3-(2,2,2-trimethylhydrazinium) propionate salts |